ADHD Assessment and Treatment Plan
For children and adolescents with suspected ADHD, confirm the diagnosis using DSM-5 criteria with documented symptoms and impairment in multiple settings (home, school, social), then initiate age-specific treatment: behavioral therapy alone for ages 4-5 years, or FDA-approved stimulant medication combined with behavioral interventions for ages 6-17 years 1.
Diagnostic Assessment
Core Diagnostic Requirements
You must establish that DSM-5 criteria are met through:
- Multiple informant reports: Obtain standardized rating scales from parents, teachers, and other caregivers who observe the child in different settings 1
- Symptom onset before age 12 (DSM-5 updated from DSM-IV's age 7 requirement) 1
- Documented impairment in at least 2 major settings: academic, social, or occupational functioning 1
- Symptoms beyond what's expected for chronologic age (though DSM-5 doesn't explicitly require developmental age comparison, which creates a pitfall for children with developmental disorders) 1
Mandatory Comorbidity Screening
Screen for coexisting conditions as they fundamentally alter your treatment approach 1:
- Emotional/behavioral: anxiety, depression, oppositional defiant disorder, conduct disorders, substance use
- Developmental: learning disorders, language disorders, autism spectrum disorders
- Physical: tics, sleep apnea
The major risk here is misdiagnosing comorbid conditions and providing inappropriate care 1. Complex ADHD cases (age <4 or >12 years at presentation, moderate-to-severe impairment, diagnostic uncertainty, or treatment-resistant cases) warrant interprofessional assessment 2.
Treatment Algorithm by Age
Preschool-Aged Children (4-5 Years)
First-line treatment is evidence-based behavioral parent training and/or behavioral classroom interventions 1. This is a Grade A strong recommendation.
Consider methylphenidate only if:
- Behavioral interventions fail to provide significant improvement AND
- Moderate-to-severe functional disturbance persists 1
Critical caveat: In areas where evidence-based behavioral treatments are unavailable, weigh the risks of starting medication before age 6 against the harm of delaying treatment—untreated ADHD causes repeated failure experiences that compound long-term outcomes 1, 3.
Elementary and Middle School Children (6-12 Years)
Prescribe FDA-approved ADHD medications (stimulants as first-line) combined with parent training and behavioral classroom interventions—preferably both behavioral modalities 1. This represents the strongest evidence base.
Stimulant medications (amphetamine and methylphenidate) show the best outcomes and are considered first-line pharmacologic treatment 4. The benefits of early treatment far outweigh risks, as untreated ADHD leads to worse academic, occupational, and social outcomes, plus increased antisocial behavior, driving problems, and substance use 3.
Adolescents and Complex Cases
Continue the combined medication and behavioral approach. Monitor stimulant use closely in patients with substance abuse concerns, but don't withhold treatment—studies support stimulant use even in adolescents with substance abuse histories due to net benefits 4.
Ongoing Management
- Reassess frequently and adjust treatment as ADHD is a chronic condition 5
- Re-evaluate patients showing minimal improvement to ensure diagnostic accuracy 4
- Address family functioning, which is highly affected by the child's ADHD 3
- Recognize that symptoms often persist into adolescence and adulthood (approximately 50% of childhood cases), requiring long-term management 4
Common Pitfalls to Avoid
- Failing to obtain multi-setting documentation—single-source reports are insufficient 1
- Missing comorbid conditions—they're present in the majority of cases and require concurrent treatment 1
- Misdiagnosing developmental disorders as ADHD due to DSM-5's lack of explicit developmental age criteria 1
- Withholding stimulants in substance-using adolescents—evidence supports their use 4
- Starting medication in preschoolers before trying behavioral interventions (unless behavioral therapy is unavailable) 1
Family preference is essential in determining the treatment plan, but the clinical evidence strongly supports combined pharmacologic and behavioral approaches for school-aged children 1.